| OA04.04 | Design and testing of a cabotegravir reservoir implant for HIV prevention | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |
| PE05.04 | Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation | E-poster | Community engagement in prevention research |
| PE08.08LB | Design of enzyme responsive microspheres of maraviroc and tenofovir in a smart vaginal gel for pre-exposure prophylaxis of HIV-1 | E-poster | Delivery technologies: novel approaches, formulation and multi-purpose |
| PE01.09 | Developing a chatbot for HIV risk assessment among young people living in Soweto, South Africa | E-poster | Behavioural and social science research |
| OA08.05LB | Development of a novel VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies | Oral Abstract Session | Novel vaccine and other prevention approaches |
| PE07.05 | Development of a probe to identify SARS-CoV2 infected cells in rhesus macaques | E-poster | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PE05.05 | Devising an integrated and creative response to support participant retention in a global biomedical HIV prevention study during the COVID-19 pandemic | E-poster | Community engagement in prevention research |
| PE22.01 | Directly Observed Therapy (DOT) can be Implemented Successfully in Research Settings to Evaluate PrEP PK among Pregnant and Postpartum Adolescents and Young Women in Africa | E-poster | Novel vaccine and other prevention approaches |
| OA05.04 | Disruption of immune cell homeostasis within rectal mucosal tissue of HIV+ young men who have sex with men | Oral Abstract Session | Mucosal immunity |
| PU21.08 | Distinct classes of HIV-1 cross-clade neutralizing antibodies targeting fusion peptide elicited in mice by diverse immunization regimens | Publication Only | Novel vaccine and other prevention approaches |